The vaccines developed over the first two hundred years since Jenner's lifetime have
accomplished striking reductions of infection and disease wherever applied. Pasteur's early …

This paper attempts to summarize current knowledge about immune responses to vaccines
that correlate with protection. Although the immune system is redundant, almost all current …

Identification of immune correlates of protection after vaccination is an important part of
vaccinology for both theoretical and practical reasons. The terminology and definition of …

Vaccine development, which began with Edward Jenner's observations in the late 18th
century, has entered its 4th century. From its beginnings, with the use of whole organisms that …

Although the demonstration in 1796 by Edward Jenner that vaccinia virus could protect against
smallpox was epochal, he was following the path opened by the ancients who had used …

Vaccine design and licensing depend on the choice of protective antigens and the
demonstration of their efficacy. Ideally efficacy correlates with some measurement of immune …

The immune system is redundant, and B and T cells collaborate. However, almost all current
vaccines work through induction of antibodies in serum or on mucosa that block infection or …

A correlate of protection (CoP) is urgently needed to expedite development of additional
COVID-19 vaccines to meet unprecedented global demand. To assess whether antibody titers …

Completely revised and updated, this respected reference offers comprehensive and current
coverage of every aspect of vaccination-from development to use in reducing disease. It …

In the 20th century, the development, licensing and implementation of vaccines as part of
large, systematic immunization programs started to address health inequities that existed …